Your browser doesn't support javascript.
loading
Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study.
Cui, Xinge; Wang, Shaoyuan; Gao, Huitao; Li, Baolan; Shi, Yuankai; Guo, Haifang; Song, Tingting; Zheng, Xin.
Afiliación
  • Cui X; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Beijing 100032, China.
  • Wang S; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Beijing 100032, China.
  • Gao H; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Beijing 100032, China.
  • Li B; Being Chest Hospital, Capital Medical University, Beijing 101149, China.
  • Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
  • Guo H; Jiangsu Aosaikang Pharmaceutical Co. Ltd., Nanjing 211112, China.
  • Song T; Jiangsu Aosaikang Pharmaceutical Co. Ltd., Nanjing 211112, China.
  • Zheng X; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Beijing 100032, China. Electronic address: zhengxin1@pumch.cn.
Article en En | MEDLINE | ID: mdl-33360679

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cromatografía Líquida de Alta Presión / Inhibidores Enzimáticos / Espectrometría de Masas en Tándem / Receptores ErbB / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Chromatogr B Analyt Technol Biomed Life Sci Asunto de la revista: ENGENHARIA BIOMEDICA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cromatografía Líquida de Alta Presión / Inhibidores Enzimáticos / Espectrometría de Masas en Tándem / Receptores ErbB / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Chromatogr B Analyt Technol Biomed Life Sci Asunto de la revista: ENGENHARIA BIOMEDICA Año: 2021 Tipo del documento: Article País de afiliación: China